| 113.38 Real-Time Quote |  +1.18 / +1.05%Today’s Change | 58.53 Today|||52-Week Range 131.82 | +44.49% Year-to-Date |
| Celgene Soars in 2013; What Does the Future Hold? 1:22pm / MotleyFool.com | Revlimid Gains, Celgene Loses Jun 05 / MotleyFool.com |
| A Reality Check Before You Buy 11:08am / TheStreet.com | Setback for Pluristem Therapeutics - Analyst Blog Jun 05 / Zacks.com |
| Interesting CELG Put And Call For June 14th 11:06am / TheStreet.com | Celgene Presents Data at ASCO - Analyst Blog Jun 05 / Zacks.com |
| 'Mad Money' Lightning Round: Amgen's Not a Fave 6:06am / TheStreet.com | Celgene Corporation (CELG): Today's Featured Health Care Laggard Jun 04 / TheStreet.com |
| Today's 3 Worst Stocks Jun 05 / MotleyFool.com | CELG, AMGN, GILD, JNJ And PFE, Pushing Drugs Industry Downward Jun 04 / TheStreet.com |
| Previous close | 112.20 |
| Today’s open | 112.01 |
| Day’s range | 111.50 - 114.35 |
| Volume | 2,441,842 |
| Average volume (3 months) | 3,168,901 |
| Market cap | $46.8B |
| Dividend yield | -- |
| Earnings growth (last year) | +15.79% |
| Earnings growth (this year) | +16.59% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +12.05% |
| P/E ratio | 34.3 |
| Price/Sales | 6.23 |
| Price/Book | 8.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABTAbbott Laboratories | +0.28 | +0.77% |
| LLYEli Lilly and Co | -0.01 | -0.02% |
| AZNAstraZeneca PLC | +0.46 | +0.91% |
| AGNAllergan Inc | +1.50 | +1.54% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.43 |
| Annual revenue (last year) | $5.4B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 26.84% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert J. Hugin, MBA |
Chief Operating Officer & Executive Vice President Perry A. Karsen |
Corporate headquarters Summit, New Jersey |
.
